Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder.
Jan EngelmannHarald MurckStefanie WagnerLea ZillichFabian StreitDavid P HerzogDieter F BrausAndre TadicKlaus LiebMarianne B MűllerPublished in: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry (2022)
clinicaltrials.gov Identifier: NCT00974155; https://www.clinicaltrials.gov/ct2/results?term=NCT00974155.
Keyphrases
- major depressive disorder
- bipolar disorder
- study protocol
- computed tomography
- phase iii
- depressive symptoms
- image quality
- preterm infants
- dual energy
- clinical trial
- contrast enhanced
- phase ii
- healthcare
- sleep quality
- positron emission tomography
- adverse drug
- randomized controlled trial
- magnetic resonance imaging
- physical activity
- preterm birth